title: Controlled-release delivery of L-dopa associated with nonfatal hyperthermia, rigidity, and autonomic dysfunction.
authors.affiliation: Department of Neurology, Austin Hospital, Heidelberg, Victoria, Australia.
authors.forename: M A
authors.initials: MA
authors.lastname: Cunningham
authors.forename: D G
authors.initials: DG
authors.lastname: Darby
authors.forename: G A
authors.initials: GA
authors.lastname: Donnan
mesh_terms: D000328:Adult; D001342:Autonomic Nervous System Diseases / Q000139:chemically induced*; D001545:Benserazide / Q000009:adverse effects* / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009127:Muscle Rigidity / Q000139:chemically induced*; D010300:Parkinson Disease / Q000188:drug therapy
chemical_list: D003692:Delayed-Action Preparations; D004338:Drug Combinations; C005177:benserazide, levodopa drug combination; D007980:Levodopa; D001545:Benserazide